Recent data reveal that current approaches to neurointervention are moderately effective and have limitations:
Route 92 Medical is continually striving to improve outcomes for patients undergoing neurovascular intervention.
Our portfolio takes aim at unmet neurointervention needs to deliver more meaningful solutions.
Recent data reveal that current approaches to neurointervention are moderately effective and have limitations:
Large-bore catheters are often not able to navigate through tortuous curves and past vessel origins1
Conventional devices can take too long to reach a target location
Current technologies have high rates of failure in reaching the target location
Clinicians often must create “work-arounds” to make devices from different companies work together
Learn how Route 92 Medical is overcoming these limitations with advanced products and an innovative approach.
The FreeClimb 54, FreeClimb 70, and FreeClimb 88 catheter systems are advanced neurointervention systems designed to provide superior performance—even in the most tortuous anatomy.
Refining AccessThe SUMMIT MAX trial is currently underway to evaluate the safety and efficacy of the Monopoint Reperfusion System. The platform was designed to streamline delivery and enable super-bore aspiration at the most common stroke targets.
CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.
Transforming Intervention